Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Apexxnar“
Suchtreffer
Begriffe & Kennungen
Prevenar 20 (previously Apexxnar)
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.1 Therapeutic indications · 1
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.3 Contraindications · 1
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.3 · Hypersensitivity to the active substances, to any of the excipients listed in section 6.1, or to diphtheria to
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.5 · 6 Individuals 18 years of age and older
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.5 · Different injectable vaccines should always be administered at different vaccination sites.
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.5 · Do not mix Prevenar 20 with other vaccines or medicinal products in the same syringe.
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.5 · In infants and children, 6 weeks to less than 5 years of age, Prevenar 20 can be administered concomitantly wi
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.5 · Paediatric population
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.5 · Prevenar 20 can be administered concomitantly with COVID-19 mRNA vaccine (nucleoside modified).
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.5 · Prevenar 20 may be administered concomitantly with seasonal influenza vaccine (QIV; surface antigen, inactivat
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.5 · There are no data on the concomitant administration of Prevenar 20 with other vaccines.
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.8 Undesirable effects · 1
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.8 · 10 Table 1. Tabulated Adverse Reactions From Prevenar 20 Clinical Trials System Organ Adverse Reactions Freque
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.8 · 11 trial B7471026 (Study 1026), pyrexia (13.0%) and chills (26.5%) were reported as “very common” with co-admi
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.8 · 7 clinical trials and 1 single-arm clinical trial; 3 664 participants received at least 1 dose of Prevenar 20,
Eintrag öffnenPrevenar 20 (previously Apexxnar) · 4.8 · 8 drowsiness/increased sleep (41.7%), redness at the injection site (37.7%), decreased appetite (25.0%), swell
Eintrag öffnen